TRENAL Research

TRENAL focusses on all aspects of kidney  research – from physiology to clinical application.

Research groups

Polycystic kidney disease
Polycystic kidney disease
Wilson, Patricia
CKD and cardiovascular disesae (CVD) risk
Wheeler, David
, , ,
Renal Tubular Physiology
Renal Tubular Physiology
Walsh, Stephen
Novel mechanisms of vascular calcification as therpautic targets
Voelkl Jakob & Alesutan Ioana
, ,
Polycystic Kidney and Liver Disease Research
Somlo, Stefan


Why kidney research


The global burden of kidney disease

In the past decade, kidney disease diagnosed with objective measures of kidney damage and function has been recognised as a major public health burden. The population prevalence of chronic kidney disease exceeds 10%, and is more than 50% in high-risk subpopulations. Independent of age, sex, ethnic group, and comorbidity, strong, graded, and consistent associations exist between clinical prognosis and two hallmarks of chronic kidney disease: reduced glomerular filtration rate and increased urinary albumin excretion. Furthermore, an acute reduction in glomerular filtration rate is a risk factor for adverse clinical outcomes and the development and progression of chronic kidney disease. An increasing amount of evidence suggests that the kidneys are not only target organs of many diseases but also can strikingly aggravate or start systemic pathophysiological processes through their complex functions and effects on body homoeostasis. Risk of kidney disease has a notable genetic component, and identified genes have provided new insights into relevant abnormalities in renal structure and function and essential homoeostatic processes. Collaboration across general and specialised health-care professionals is needed to fully address the challenge of prevention of acute and chronic kidney disease and improve outcomes.